FDA Approves Cepheid’s Multiplex Viral Hemorrhagic Fever Panel

Cepheid, a Danaher company, announced that the FDA has cleared its Xpert Hemorrhagic Fever Panel, a multiplex PCR test capable of detecting viral RNA from a single sample. The test delivers results in approximately 61 minutes using GeneXpert Dx systems. This approval marks a significant advancement in rapid diagnostic testing for viral hemorrhagic fevers.

Originally published by gnews